Antineoplastic preparation "Sehydrin": instruction for use

The drug "Sehydrin" instruction refers to a group of antitumor drugs that effectively suppress the growth of neoplasms. This tool is based on inhibition of MAO, increase in albumin and glucose tolerance, and integrative effects on a number of biochemical processes. The reception of the preparation "Sehydrin" (instruction confirms) contributes to cessation of energy losses, provides the reverse development of the processes of weight loss and body exhaustion due to tumor growth, and also allows to reduce the permeability of biomembranes and cell membranes by slowing the metabolism of xenobiotics. In this case, this medicine does not have any mielodepressivnogo action and for a relatively short time eliminates a sense of weakness, pain, fever and such phenomena of respiratory failure as cough and shortness of breath.

An increase in motor activity and an improvement in appetite also provides an antitumor drug "Sehydrin", the price for which is on average 1200-1400 rubles.

This drug is currently produced exclusively in the form of tablets of red-brown color. Each pellet contains about sixty milligrams of hydrazine sulphate as the main active ingredient. Auxiliary components are polyvinylpyrrolidone, polyethylene glycol 600, highly dispersed silica , disubstituted calcium phosphate, polymethacrylate, magnesium stearate, red iron oxide, dimethicone, titanium dioxide and talc.

Take the preparation of "Sehydrin" instructions for use to treat patients with inoperable progressive disseminated and locally advanced forms of malignant tumors, metastases of malignant tumors or relapses. For example, this drug is prescribed for neuroblastoma, lymphosarcoma, astrocytoma, glioblastoma and other brain tumors, lung cancer, larynx, cervix or endometrium, as well as for lymphogranulomatosis, tumors in the mammary glands. When desmoid soft tissue also shows the use of the drug "Sehydrin." The instruction recommends using it and people with fibrosarcoma.

It is strictly forbidden to prescribe this antineoplastic agent in case of individual patient intolerance to hydrazine sulphate or if he has an allergic reaction to any additional substances contained in the formulation. With extreme caution, experts advise taking this drug to people with severe impaired renal or hepatic function. In addition, during the period of therapy is contraindicated the use of any type of alcohol by the patient. Also, do not combine this drug with barbiturates to avoid a sharp increase in toxicity. During pregnancy, it is likewise not recommended to take Sehydrin tablets. The instruction does not recommend using them during the lactation period.